A retrospective study will investigate the efficacy of trastuzumab in the patients with HER2–positive, tamoxifen-refractory breast cancer with brain metastasis

Trial Profile

A retrospective study will investigate the efficacy of trastuzumab in the patients with HER2–positive, tamoxifen-refractory breast cancer with brain metastasis

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2016

At a glance

  • Drugs Trastuzumab (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Feb 2016 New trial record
    • 20 Jan 2016 Results published in the BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top